COST-EFFICACY ANALYSIS OF CHRONIC HEPATITIS B TREATMENT IN A REAL-LIFE SETTING OF THE NORTHERN-ITALY

被引：0
|
作者：
Pecere, S. [1 ]
Fagiuoli, S. [1 ]
Pasulo, L. [1 ]
Luca, M. G. [1 ]
Cologni, G. [2 ]
Rizzi, M. [2 ]
Colpani, M. [1 ]
Bitetto, D. [1 ]
Benatti, S. V. [2 ]
Mels, G. Colloredo [3 ]
Del Poggio, P. [4 ]
Fracassetti, O. [5 ]
Spinetti, A. [6 ]
Paraninfo, G. [6 ]
Zaltron, S. [6 ]
Castelli, F. [6 ]
Mirandola, S. [7 ]
Di Matteo, S. [8 ]
Colombo, G. L. [8 ,9 ]
机构：
[1] Papa Giovanni XXIII Hosp, Gastroenterol & Transplant Hepatol, Bergamo, Italy
[2] Papa Giovanni XXIII Hosp, Dept Infect Dis, Bergamo, Italy
[3] Ponte S Pietro Hosp, Dept Med, Bergamo, Italy
[4] Zingonia Hosp, Dept Med, Zingonia, Bg, Italy
[5] Treviglio Hosp, Dept Med, Treviglio, Italy
[6] Univ Brescia, Dept Infect Dis, I-25121 Brescia, Italy
[7] Gilead Sci, Med Affairs, Milan, Italy
[8] SAVE Studi Anal Valutaz Econ, Milan, Italy
[9] Univ Pavia, Dept Drug Sci, Sch Pharm, I-27100 Pavia, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2014年 / 46卷
关键词：
D O I：
10.1016/j.dld.2014.01.052
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
T-12
引用
收藏
页码：E22 / E23
页数：2
相关论文
共 50 条
  • [21] Treatment of chronic hepatitis B in India: What is the cost of life?
    Anand, AC
    NATIONAL MEDICAL JOURNAL OF INDIA, 2002, 15 (06): : 317 - 319
  • [22] TREATMENT OF CHRONIC HEPATITIS C GENOTYPE 1 IN POLAND - REAL-LIFE DATA
    Kaczor, M. P.
    Pawlik, D.
    Wojcik, R.
    Rolka, M.
    Maniszewska-Weyher, I
    Tronczynski, K.
    VALUE IN HEALTH, 2012, 15 (07) : A326 - A326
  • [23] Long-Term Treatment Outcome of Entecavir (ETV) Monotherapy in Treatment-Naive Hepatitis B e Antigen-positive Chronic Hepatitis B (CHB) Patients in a Real-Life Setting
    Ha, Nghi
    Ha, Nghiem
    Garcia, Ruel
    Trinh, Huy
    Do, Ailinh
    Nguyen, Huy
    Nguyen, Khanh
    Levitt, Brian
    Nguyen, Mindie
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 : S131 - S132
  • [24] High prevalence of acute onset autoimmune hepatitis in males: A real-life cohort from Northern Italy
    Donato, Maria Francesca
    Rigamonti, Cristina
    Monico, Sara
    Vinci, Maria
    Colapietro, Francesca
    del Poggio, Paolo
    Colloredo, Guido
    DIGESTIVE AND LIVER DISEASE, 2019, 51 (01) : 172 - 173
  • [25] Comparable efficacy of tenofovir versus entecavir and predictors of response in treatment-naive patients with chronic hepatitis B: a multicenter real-life study
    Batirel, Ayse
    Guclu, Ertugrul
    Arslan, Ferhat
    Kocak, Funda
    Karabay, Oguz
    Ozer, Serdar
    Turanli, Munevver
    Mert, Ali
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2014, 28 : 153 - 159
  • [26] Long-term entecavir therapy of chronic hepatitis B in real-life setting-Importance of quantitative HBsAg level
    Ray, Gautam
    INDIAN JOURNAL OF GASTROENTEROLOGY, 2024, 43 (03) : 652 - 659
  • [27] PITER: An ongoing nationwide study on the real-life impact of direct acting antiviral based treatment for chronic hepatitis C in Italy
    Kondili, Loreta A.
    Vella, Stefano
    DIGESTIVE AND LIVER DISEASE, 2015, 47 (09) : 741 - 743
  • [28] Real-life experience of direct acting antiviral treatment for chronic hepatitis C infection in adolescent patients in a low prevalence setting
    Flanagan, Mary
    Goode, Michelle
    Rochford, Annette
    McDonagh, Sinead
    O'Connor, Maura
    Rafferty, Aisling
    Butler, Karina
    Gavin, Patrick
    JOURNAL OF HEPATOLOGY, 2020, 73 : S353 - S354
  • [29] Loss of hepatitis B surface antigen in a real-life clinical cohort of patients with chronic hepatitis B virus infection
    Habersetzer, Francois
    Moenne-Loccoz, Remy
    Meyer, Nicolas
    Schvoerer, Evelyne
    Simo-Noumbissie, Pauline
    Dritsas, Stavros
    Baumert, Thomas F.
    Doffoel, Michel
    LIVER INTERNATIONAL, 2015, 35 (01) : 130 - 139
  • [30] Cost-efficacy analysis of peginterferon-α2b plus ribavirin compared to peginterferon-α2a plus ribavirin for treatment of chronic hepatitis C
    Malone, DC
    Tran, TT
    PHARMACOTHERAPY, 2004, 24 (10): : 1456 - 1457
12345